A detailed history of Rhumbline Advisers transactions in Illumina, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 456,589 shares of ILMN stock, worth $64 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
456,589
Previous 462,616 1.3%
Holding current value
$64 Million
Previous $48.3 Million 23.3%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$105.28 - $135.9 $634,522 - $819,069
-6,027 Reduced 1.3%
456,589 $59.5 Million
Q2 2024

Aug 01, 2024

BUY
$101.05 - $133.57 $18.2 Million - $24.1 Million
180,196 Added 63.8%
462,616 $48.3 Million
Q1 2024

May 09, 2024

BUY
$127.73 - $147.2 $62,970 - $72,569
493 Added 0.17%
282,420 $38.8 Million
Q4 2023

Feb 08, 2024

SELL
$92.79 - $142.53 $136,772 - $210,089
-1,474 Reduced 0.52%
281,927 $39.3 Million
Q3 2023

Nov 09, 2023

SELL
$128.91 - $192.44 $142,703 - $213,031
-1,107 Reduced 0.39%
283,401 $38.9 Million
Q2 2023

Aug 08, 2023

BUY
$183.43 - $232.67 $2.6 Million - $3.3 Million
14,177 Added 5.24%
284,508 $53.3 Million
Q1 2023

May 11, 2023

BUY
$193.75 - $232.55 $683,550 - $820,436
3,528 Added 1.32%
270,331 $62.9 Million
Q4 2022

Feb 14, 2023

BUY
$187.24 - $242.74 $1.85 Million - $2.4 Million
9,902 Added 3.85%
266,803 $53.9 Million
Q3 2022

Nov 10, 2022

BUY
$177.23 - $227.44 $1.48 Million - $1.9 Million
8,367 Added 3.37%
256,901 $49 Million
Q2 2022

Aug 11, 2022

BUY
$181.58 - $368.0 $4.33 Million - $8.78 Million
23,864 Added 10.62%
248,534 $45.8 Million
Q1 2022

May 12, 2022

BUY
$303.87 - $423.8 $1.53 Million - $2.13 Million
5,030 Added 2.29%
224,670 $78.5 Million
Q4 2021

Feb 10, 2022

BUY
$347.28 - $421.83 $4.5 Million - $5.47 Million
12,960 Added 6.27%
219,640 $83.6 Million
Q3 2021

Nov 12, 2021

SELL
$405.61 - $524.84 $1.55 Million - $2.01 Million
-3,826 Reduced 1.82%
206,680 $83.8 Million
Q2 2021

Aug 05, 2021

SELL
$372.84 - $481.5 $4.78 Million - $6.17 Million
-12,808 Reduced 5.74%
210,506 $99.6 Million
Q1 2021

May 06, 2021

SELL
$361.28 - $504.76 $4.7 Million - $6.57 Million
-13,015 Reduced 5.51%
223,314 $85.8 Million
Q4 2020

Feb 10, 2021

SELL
$292.7 - $370.96 $12.5 Million - $15.8 Million
-42,550 Reduced 15.26%
236,329 $87.4 Million
Q3 2020

Nov 12, 2020

SELL
$268.51 - $400.74 $288,916 - $431,196
-1,076 Reduced 0.38%
278,879 $86.2 Million
Q2 2020

Aug 13, 2020

BUY
$256.46 - $373.01 $3.55 Million - $5.17 Million
13,857 Added 5.21%
279,955 $104 Million
Q1 2020

May 06, 2020

BUY
$209.2 - $335.53 $360,451 - $578,118
1,723 Added 0.65%
266,098 $72.7 Million
Q4 2019

Feb 05, 2020

SELL
$288.29 - $335.49 $666,526 - $775,652
-2,312 Reduced 0.87%
264,375 $87.7 Million
Q3 2019

Oct 23, 2019

BUY
$266.84 - $378.23 $898,450 - $1.27 Million
3,367 Added 1.28%
266,687 $81.1 Million
Q2 2019

Aug 14, 2019

SELL
$300.59 - $368.15 $2.53 Million - $3.1 Million
-8,410 Reduced 3.09%
263,320 $96.9 Million
Q1 2019

May 01, 2019

BUY
$272.57 - $321.18 $4 Million - $4.71 Million
14,658 Added 5.7%
271,730 $84.4 Million
Q4 2018

Jan 31, 2019

BUY
$272.46 - $366.54 $2.14 Million - $2.88 Million
7,857 Added 3.15%
257,072 $77.1 Million
Q3 2018

Nov 07, 2018

SELL
$279.04 - $367.06 $1.83 Million - $2.41 Million
-6,560 Reduced 2.56%
249,215 $91.5 Million
Q2 2018

Aug 06, 2018

SELL
$228.17 - $292.07 $5.05 Million - $6.46 Million
-22,129 Reduced 7.96%
255,775 $71.4 Million
Q1 2018

May 02, 2018

SELL
$209.54 - $253.91 $1.43 Million - $1.74 Million
-6,841 Reduced 2.4%
277,904 $65.7 Million
Q4 2017

Feb 09, 2018

BUY
$202.23 - $230.03 $1.41 Million - $1.6 Million
6,950 Added 2.5%
284,745 $62.2 Million
Q3 2017

Nov 06, 2017

BUY
$172.3 - $213.93 $47.9 Million - $59.4 Million
277,795
277,795 $55.3 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.